ANDREW P. COMBS,JAMES D. RODGERS,RICHARD B. SPARKS,THOMAS P. MADUSKUIE JR.
申请号：
BR112015022942
公开号：
BR112015022942A2
申请日:
2014.03.14
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention relates to tricyclic heterocycles which are inhibitors of beta proteins such as brd2, brd3, brd4, and brd-t and are useful in the treatment of diseases such as cancer. Tricyclic heterocycles as inhibitors of bet protein The present invention relates to tricyclic heterocycles that are inhibitors of bet proteins such as brd2, brd3, brd4 and brd-t and are useful in treating diseases such as cancer.abstract the present invention relates to tricyclic heterocycles which are inhibitors of bet proteins such as brd2, brd3, brd4, and brd-t and are useful in the treatment of diseases such as cancer. tradução do resumo resumo heterociclos tricíclicos como inibidores da proteína bet a presente invenção refere-se aos heterocíclicos tricíclicos que são inibidores das proteínas bet como brd2, brd3, brd4 e brd-t e são úteis no tratamento de doenças como o câncer.
